What is the current Price Target for the I-Mab - ADR stock?

The average I-Mab - ADR target price is $7.14. This is 78.50% higher than the current stock price. The highest price target is 110.00%, the lowest is 51.50%. 7 Analysts have issued a price target I-Mab - ADR 2026 .

How high will the I-Mab - ADR stock rise?

No reliable answer can be given as to how high the I-Mab - ADR stock will rise. The performance of stocks, including the I-Mab - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the I-Mab - ADR stock today?

The performance of I-Mab - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the I-Mab - ADR stock fall?

The decline in I-Mab - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

I-Mab - ADR Forecast, price target & analysts

$4.21

1.17% day before yesterday

Nasdaq, Nov 06, 03:30 pm CET

ISIN

US44975P1030

Symbol

IMAB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

I-Mab - ADR Target price 2025 - Analyst rating & recommendation

I-Mab - ADR Classifications & Recommendation:

Buy

92%

Hold

I-Mab - ADR Price Target

Target Price	$7.14
Price	$4.00
Potential	78.50% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target I-Mab - ADR 2026 . The average I-Mab - ADR target price is $7.14. This is 78.50% register free of charge higher than the current stock price. The highest price target is $8.40 110.00% register free of charge , the lowest is $6.06 51.50% register free of charge .
	A rating was issued by 12 analysts: 11 Analysts recommend I-Mab - ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the I-Mab - ADR stock has an average upside potential 2026 of 78.50% register free of charge . Most analysts recommend the I-Mab - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.11	-0.10
	89.81%	9.09%
P/E		negative

9 Analysts have issued a I-Mab - ADR forecast for earnings per share. The average I-Mab - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.11	89.81%
2025	$-0.10 9.09% Unlock
2026	$-0.33 230.00% Unlock
2027	$-0.48 45.45% Unlock
2028	$-0.50 4.17% Unlock
2029	$-0.41 18.00% Unlock
2030	$0.20 148.78% Unlock
2031	$0.23 15.00% Unlock
2032	$0.51 121.74% Unlock

Current	-18.18	715.62%
2025	-39.22 115.71% Unlock
2026	-12.07 69.22% Unlock
2027	-8.34 30.90% Unlock
2028	-8.04 3.60% Unlock
2029	-9.68 20.40% Unlock
2030	19.61 302.58% Unlock
2031	17.05 13.05% Unlock
2032	7.84 54.02% Unlock

I-Mab - ADR...

Current I-Mab - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BTIG	Locked ➜ Locked	Locked	Oct 24 2025
BTIG	Locked ➜ Locked	Locked	Oct 17 2025
Leerink Partners	Locked ➜ Locked	Locked	Oct 03 2025
BTIG	Locked ➜ Locked	Locked	Sep 10 2025
BTIG	Locked ➜ Locked	Locked	Sep 09 2025
Needham	Locked ➜ Locked	Locked	Sep 08 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 21 2025

Analyst Rating	Date
Locked BTIG: Locked ➜ Locked	Oct 24 2025
Locked BTIG: Locked ➜ Locked	Oct 17 2025
Locked Leerink Partners: Locked ➜ Locked	Oct 03 2025
Locked BTIG: Locked ➜ Locked	Sep 10 2025
Locked BTIG: Locked ➜ Locked	Sep 09 2025
Locked Needham: Locked ➜ Locked	Sep 08 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 21 2025

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now